Insights

Diagnosing Tumors at Home? The Digital Transition of Healthcare Is Here

In this video clip from a Motley Fool Live interview, recorded on April 11, KPMG Partner Kristin Pothier answers a question from Fool.com contributor Rachel Warren about some of the interesting new virtual trends in telehealth. 

Kristin Pothier: A lot of the work that we do is with health systems. Health systems have seen this transition to digital health, this transition to telehealth, teletherapy, especially in mental health. It has really helped a number of patients that maybe either couldn’t get to the doctor or weren’t comfortable getting to the doctor.
Now we have family health ability where families can sit in their own living rooms with their therapist on the other end of the line and really talk through things and be able to do it where they don’t miss appointments. They don’t have to worry about getting on their bus or in their car to go to a therapy area and actually make that help for the mental health community.
I would say for the rest of telehealth as well, there are some things that you need to see a doctor for. That will never go away. In order to have a biopsy done, in order to really work into understanding a diagnosis, usually you have to see a patient. But we are seeing even in areas that have classically only been able to be done in the hospital is starting to branch out.
For example, the trend of liquid biopsy, which means instead of taking a chunk of tumor out of a patient, you take a sample of blood and you’re able to look at the signature of the tumor in the blood. This is something that can be done at home. When you really look at this and you see the monitoring capabilities, and you see the progression of cancer care, we’re going to be doing more of that as we move forward.
That’s really all due to some of this innovation, both from a perspective of the wet chemistry, but then also the availability of the digital ecosystem that goes along with it.The Motley Fool has a disclosure policy. –

In this video clip from a Motley Fool Live interview, recorded on April 11, KPMG Partner Kristin Pothier answers a question from Fool.com contributor Rachel Warren about some of the interesting new virtual trends in telehealth. 

Kristin Pothier: A lot of the work that we do is with health systems. Health systems have seen this transition to digital health, this transition to telehealth, teletherapy, especially in mental health. It has really helped a number of patients that maybe either couldn’t get to the doctor or weren’t comfortable getting to the doctor.

Now we have family health ability where families can sit in their own living rooms with their therapist on the other end of the line and really talk through things and be able to do it where they don’t miss appointments. They don’t have to worry about getting on their bus or in their car to go to a therapy area and actually make that help for the mental health community.

I would say for the rest of telehealth as well, there are some things that you need to see a doctor for. That will never go away. In order to have a biopsy done, in order to really work into understanding a diagnosis, usually you have to see a patient. But we are seeing even in areas that have classically only been able to be done in the hospital is starting to branch out.

For example, the trend of liquid biopsy, which means instead of taking a chunk of tumor out of a patient, you take a sample of blood and you’re able to look at the signature of the tumor in the blood. This is something that can be done at home. When you really look at this and you see the monitoring capabilities, and you see the progression of cancer care, we’re going to be doing more of that as we move forward.

That’s really all due to some of this innovation, both from a perspective of the wet chemistry, but then also the availability of the digital ecosystem that goes along with it.

The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

FREE AAPL, TSLA, AMZN, PFE or MRO Share(s)
REGISTER TO BE ELIGIBLE FOR FREE SHARES
TRAVEL ACROSS THE FINANCIAL WORLD
Act Fast - Promotion Ends In
Click Here To Get Started
FREE AAPL, TSLA, AMZN, PFE or MRO Share(s)
REGISTER TO BE ELIGIBLE FOR FREE SHARES
TRAVEL ACROSS THE FINANCIAL WORLD
Act Fast - Promotion Ends In
Click Here For More Info